跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Histakon
Approved
STANDARD
Histakon
Magbro Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
520452d0b5acf8fa
Company
Magbro Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
520452d0b5acf8fa
Drug Approval Philippines Name
Histakon
Product Name
Histakon
Registration Number
DRP-13704
Brand Name
Histakon
Generic Name
Betahistine hydrochloride
Dosage Form
Tablet
Dosage Strength
16 mg
Manufacturer
Magbro Healthcare Pvt. Ltd.
Trader
India
Distributor
Pharmakon Biotec Inc.
Issuance Date
29 March 2023
Expiry Date
29 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
520452d0b5acf8fa
Type
Standard
Back to Philippines FDA Approvals
Histakon - Philippines FDA Drug Approval Details